{
    "N/R/U": "U",
    "Applicant": "Samsung Bioepis Co., Ltd.",
    "BLA Number": "761373",
    "Proprietary Name": "Pyzchiva",
    "Proper Name": "ustekinumab-ttwe",
    "BLA Type": "351(k) Interchangeable",
    "Strength": "45MG/0.5ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "December 20, 2024",
    "Ref. Product Proper Name": "ustekinumab",
    "Ref. Product Proprietary Name": "Stelara",
    "Supplement Number": "2",
    "Submission Type": "Supplement",
    "License Number": "2046",
    "Product Number": "003",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}